Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Aramark Burn

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 20 mg/1 mL
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
June 28, 2021
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Lidocaine Hydrochloride 20 mg/1 mL
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
June 28, 2021
Manufacturer
Western First Aid Safety DBA Aramark
Registration number
part348
NDC root
81238-5100
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Aramark is a first aid burn spray designed to provide temporary pain relief for minor burns. This product can help soothe discomfort associated with burns, making it a useful option for treating minor injuries at home or in other settings. With a convenient 4 fl. oz. (118 mL) size, it is easy to apply when you need quick relief.

Uses

If you’re dealing with minor burns, this medication can provide temporary relief from the pain. It’s designed to help soothe discomfort, allowing you to feel more comfortable as you heal.

Rest assured, there are no known teratogenic effects (which means it doesn’t cause birth defects) associated with this medication, making it a safer option for those who may be pregnant.

Dosage and Administration

When using burn spray for treating burns, you should apply an even layer over the cleaned affected area. For adults and children aged 2 years and older, you can do this up to 3 to 4 times a day. It's important to ensure the area is clean before applying the spray to help with healing.

If you have a child under 2 years of age, it's best to consult a physician (doctor) before using the spray. They can provide guidance on the safest and most effective treatment options for younger children.

What to Avoid

You can feel confident using this medication, as there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with it. This means that, based on the available information, there are no known reasons that would prevent you from taking this medication safely. Always remember to follow your healthcare provider's guidance and reach out if you have any questions or concerns about your treatment.

Side Effects

When using this product, it's important to remember that it is for external use only. Avoid applying it in large amounts, especially on raw or blistered skin near your eyes. If you accidentally do this, rinse the area thoroughly with water.

If your condition worsens, persists for more than 7 days, or improves and then returns, you should stop using the product and consult a doctor.

Warnings and Precautions

This product is intended for external use only, so please avoid applying it to large areas of your skin, especially if you have raw or blistered areas. Be careful not to get it near your eyes; if it does come into contact with them, rinse thoroughly with water.

If your condition worsens, persists for more than 7 days, or clears up and then returns, stop using the product and consult your doctor. Always keep this product out of reach of children. In case of accidental ingestion, seek medical help or contact the Poison Control Center immediately.

Overdose

If you or someone else has swallowed too much of a medication, it’s important to seek medical help immediately. You can contact your local Poison Control Center for guidance. Signs of an overdose can vary, but they may include unusual symptoms that are not typical for the medication.

Always err on the side of caution—if you suspect an overdose, don’t wait for symptoms to appear. Getting prompt medical attention can be crucial for safety.

Pregnancy Use

When it comes to using Aramark Burn Spray (Lidocaine HCl) during pregnancy, there is no specific information available regarding its safety, dosage adjustments, or any special precautions you should take. This means that the effects of this medication on you and your developing baby are not well-studied or documented.

If you are pregnant or planning to become pregnant, it’s important to discuss any medications you are considering with your healthcare provider. They can help you weigh the potential risks and benefits based on your individual situation. Always prioritize open communication with your doctor to ensure the best care for you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there are no known concerns about the product being passed into breast milk or any associated risks for your infant. This means you can use the product without worrying about its effects on your milk production or your baby's health.

Pediatric Use

When using burn spray for children aged 2 years and older, you can apply an even layer over the cleaned affected area up to 3-4 times a day. However, if your child is under 2 years old, it’s important to consult a physician (doctor) before using the spray. This ensures that you are taking the safest approach for your little one’s needs. Always prioritize their health and well-being by seeking professional advice when necessary.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines, dosage adjustments, or monitoring requirements mentioned for your condition in the provided information. This means that the medication may not have special considerations for those with renal impairment (kidney issues). However, it's always best to consult your healthcare provider for personalized advice and to ensure your treatment is safe and effective for your situation. They can provide guidance tailored to your health needs.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no detailed guidelines available regarding how the medication may affect you or how your liver health might influence the medication's effectiveness or safety.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have about taking this medication with your liver condition. They can help ensure that you receive the safest and most effective treatment tailored to your needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with the medication. However, always ensure that your healthcare provider is aware of all the medications you are using, as this helps them provide the best care tailored to your needs. Your safety and well-being are the top priority, so don't hesitate to ask questions or express any concerns you may have.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature, away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, please remember to discard it after use to maintain safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should apply the burn spray topically, which means you will spray it directly onto the cleaned affected area. For adults and children aged 2 years and older, use it no more than 3 to 4 times a day. If the patient is under 2 years old, it's important to consult a physician before use.

FAQ

What is Aramark?

Aramark is a First Aid Burn Spray designed for temporary pain relief for minor burns.

How do I use Aramark Burn Spray?

For adults and children 2 years and older, spray an even layer over the cleaned affected area up to 3-4 times daily. Consult a physician for children under 2 years.

Are there any contraindications for using Aramark?

No contraindications are listed for Aramark Burn Spray.

What should I do if I experience worsening symptoms?

Stop using the spray and consult a doctor if your condition worsens, continues for more than 7 days, or clears up and returns.

Is Aramark safe to use during pregnancy or while nursing?

There are no specific warnings or recommendations regarding the use of Aramark during pregnancy or lactation.

What precautions should I take when using Aramark?

Use Aramark for external use only, avoid large quantities over raw or blistered areas, and do not use near the eyes.

How should I store Aramark Burn Spray?

Store at room temperature, protect from light, and keep the container tightly closed. Discard after opening.

Packaging Info

Below are the non-prescription pack sizes of Aramark Burn (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aramark Burn.
Details

Drug Information (PDF)

This file contains official product information for Aramark Burn, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Aramark First Aid Burn Spray is formulated for the temporary relief of pain associated with minor burns. This product is available in a dosage form of 4 fluid ounces (118 mL). It is manufactured for Aramark, located in Lenexa, Kansas, with a reorder number of 50004ARA. For inquiries, the contact number is 886-362-2691.

Uses and Indications

This drug is indicated for the temporary relief of pain associated with minor burns.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, an even layer of burn spray should be applied to the cleaned affected area. This application may be performed up to 3 to 4 times daily, ensuring that the area is adequately covered without excessive application.

For children under 2 years of age, it is recommended to consult a physician prior to use to determine the appropriate course of action.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only. It is imperative that the product is not applied in large quantities, especially over raw or blistered areas, to prevent potential adverse effects. Care should be taken to avoid contact with the eyes; in the event of accidental exposure, the affected area should be rinsed thoroughly with water.

Healthcare professionals should advise patients to discontinue use and seek medical advice if the condition worsens, persists for more than 7 days, or if symptoms resolve and then return.

To ensure safety, this product must be kept out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware that the product is intended for external use only. It is important to avoid using the product in large quantities, especially over raw or blistered areas near the eyes. In the event of accidental application to these sensitive areas, it is advised to rinse thoroughly with water.

Participants are instructed to discontinue use and consult a healthcare professional if their condition worsens, persists for more than 7 days, or if the condition clears up and then returns. These precautions are essential to ensure the safety and well-being of patients using the product.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Aramark Burn (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aramark Burn.
Details

Pediatric Use

Pediatric patients aged 2 years and older may use the burn spray by applying an even layer over the cleaned affected area up to 3-4 times daily. For infants and children under 2 years of age, it is advised to consult a physician prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of Aramark Burn Spray (Lidocaine HCl) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pregnant patients, as the potential risks and benefits have not been established. It is advisable to weigh the necessity of treatment against any unknown risks to fetal outcomes. Women of childbearing potential should be informed of the lack of data and encouraged to discuss any concerns with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution and consider the overall clinical context when prescribing this medication to patients with hepatic impairment, as individual responses may vary.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact the Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management of overdosage should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact the Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with specific directions for use in adults and children aged 2 years and older. Patients should spray an even layer of the burn spray over the cleaned affected area, not exceeding 3-4 applications daily. For children under 2 years of age, it is advised to consult a physician prior to use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Aramark Burn, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Aramark Burn, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.